Cadrenal Therapeutics, Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -25,088.3% | – | – | – | -83,913.1% | – | – | – | – | – | – | – | |
| – | 21.6% | – | – | – | 19.1% | – | – | – | – | – | – | – | |
| – | 3,725.3% | – | – | – | 35,764.2% | – | – | – | – | – | – | – | |
| – | 12,495.6% | – | – | – | 76,522.2% | – | – | – | – | – | – | – | |
| – | 117.6% | – | – | – | 306.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -306.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | -451.6% | – | – | – | 349,169.9% | – | – | – | – | – | – | – | |
| – | -25,539.9% | – | – | – | 264,950.4% | – | – | – | – | – | – | – | |
| – | -25,205.9% | – | – | – | -84,219.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.